Lizdany Alvarez-Florez
Medellin, ANT, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Natural Resistance to HIV Infection: Role of Immune Activation.
Journal: Immunity, inflammation and disease
Published: October 16, 2024
Comparison among plaque assay, tissue culture infectious dose (TCID50) and real-time RT-PCR for SARS-CoV-2 variants quantification.
Journal: Iranian journal of microbiology
Published: May 01, 2023
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections.
Journal: Communications biology
Published: January 12, 2023
Neutralizing antibody titers to Omicron six months after vaccination with BNT162b2 in Colombia.
Journal: Frontiers in immunology
Published: November 18, 2022
Hemorrhagic fever viruses: Pathogenesis, therapeutics, and emerging and re-emerging potential.
Journal: Frontiers in microbiology
Published: September 08, 2022
In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach.
Journal: AIMS microbiology
Published: September 05, 2022
Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et).
Journal: Frontiers in medicine
Published: July 12, 2022
Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months.
Journal: Frontiers in immunology
Published: February 18, 2022
SM-COLSARSPROT: Highly Immunogenic Supramutational Synthetic Peptides Covering the World's Population.
Journal: Frontiers in immunology
Published: January 21, 2022
Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.
Journal: Molecules (Basel, Switzerland)
Published: October 14, 2021
Atorvastatin Effectively Inhibits Ancestral and Two Emerging Variants of SARS-CoV-2 in vitro.
Journal: Frontiers in microbiology
Published: June 06, 2021
Last Updated: 09/26/2026